China Resources Medical Holdings Company Ltd
HKEX:1515
Income Statement
Earnings Waterfall
China Resources Medical Holdings Company Ltd
Revenue
|
10.1B
CNY
|
Cost of Revenue
|
-8.2B
CNY
|
Gross Profit
|
1.9B
CNY
|
Operating Expenses
|
-871.8m
CNY
|
Operating Income
|
1B
CNY
|
Other Expenses
|
-776.4m
CNY
|
Net Income
|
257.7m
CNY
|
Income Statement
China Resources Medical Holdings Company Ltd
Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||
Revenue |
887
N/A
|
975
+10%
|
1 206
+24%
|
1 302
+8%
|
1 372
+5%
|
1 475
+8%
|
1 533
+4%
|
1 690
+10%
|
1 878
+11%
|
1 932
+3%
|
2 059
+7%
|
2 108
+2%
|
2 115
+0%
|
2 058
-3%
|
2 751
+34%
|
3 615
+31%
|
4 447
+23%
|
5 881
+32%
|
7 901
+34%
|
9 809
+24%
|
10 108
+3%
|
|
Gross Profit | ||||||||||||||||||||||
Cost of Revenue |
(675)
|
(730)
|
(909)
|
(982)
|
(1 043)
|
(1 105)
|
(1 126)
|
(1 142)
|
(1 209)
|
(1 229)
|
(1 303)
|
(1 364)
|
(1 353)
|
(1 396)
|
(2 114)
|
(2 830)
|
(3 514)
|
(4 737)
|
(6 595)
|
(8 020)
|
(8 202)
|
|
Gross Profit |
213
N/A
|
245
+15%
|
298
+22%
|
320
+7%
|
330
+3%
|
370
+12%
|
407
+10%
|
548
+35%
|
668
+22%
|
703
+5%
|
757
+8%
|
744
-2%
|
762
+2%
|
662
-13%
|
637
-4%
|
786
+23%
|
934
+19%
|
1 144
+23%
|
1 306
+14%
|
1 790
+37%
|
1 906
+6%
|
|
Operating Income | ||||||||||||||||||||||
Operating Expenses |
(10)
|
(30)
|
(41)
|
(6)
|
(99)
|
(111)
|
(118)
|
(1 892)
|
(207)
|
(222)
|
(219)
|
(228)
|
(245)
|
(248)
|
(336)
|
(402)
|
(579)
|
(675)
|
(774)
|
(905)
|
(872)
|
|
Selling, General & Administrative |
(74)
|
(84)
|
(86)
|
(97)
|
(150)
|
(163)
|
(172)
|
(196)
|
(212)
|
(227)
|
(223)
|
(235)
|
(255)
|
(261)
|
(358)
|
(434)
|
(620)
|
(748)
|
(828)
|
(965)
|
(973)
|
|
Other Operating Expenses |
64
|
54
|
44
|
92
|
51
|
52
|
55
|
(1 696)
|
4
|
5
|
4
|
7
|
10
|
13
|
22
|
32
|
40
|
74
|
54
|
59
|
102
|
|
Operating Income |
203
N/A
|
215
+6%
|
256
+19%
|
314
+23%
|
230
-27%
|
259
+13%
|
289
+11%
|
(1 344)
N/A
|
461
N/A
|
482
+4%
|
537
+12%
|
516
-4%
|
517
+0%
|
414
-20%
|
300
-27%
|
384
+28%
|
354
-8%
|
470
+33%
|
531
+13%
|
885
+66%
|
1 034
+17%
|
|
Pre-Tax Income | ||||||||||||||||||||||
Interest Income Expense |
(35)
|
(25)
|
45
|
26
|
16
|
9
|
22
|
168
|
196
|
60
|
51
|
48
|
28
|
22
|
120
|
160
|
147
|
78
|
23
|
(17)
|
(58)
|
|
Non-Reccuring Items |
(20)
|
0
|
16
|
0
|
5
|
0
|
(1 728)
|
1
|
(97)
|
(99)
|
1
|
2
|
(1)
|
9
|
6
|
(3)
|
(224)
|
(223)
|
(131)
|
(131)
|
(484)
|
|
Total Other Income |
(4)
|
(2)
|
(1)
|
(1)
|
(3)
|
(4)
|
(36)
|
(35)
|
(1)
|
(1)
|
(0)
|
(2)
|
(3)
|
(1)
|
(8)
|
(8)
|
(7)
|
(10)
|
0
|
(2)
|
0
|
|
Pre-Tax Income |
143
N/A
|
188
+32%
|
317
+68%
|
340
+7%
|
248
-27%
|
264
+7%
|
(1 452)
N/A
|
(1 209)
+17%
|
560
N/A
|
442
-21%
|
589
+33%
|
563
-4%
|
541
-4%
|
444
-18%
|
418
-6%
|
532
+27%
|
270
-49%
|
314
+16%
|
423
+35%
|
734
+74%
|
493
-33%
|
|
Net Income | ||||||||||||||||||||||
Tax Provision |
(47)
|
(59)
|
(77)
|
(81)
|
(76)
|
(61)
|
(47)
|
(94)
|
(130)
|
(137)
|
(149)
|
(142)
|
(141)
|
(121)
|
(98)
|
(117)
|
155
|
177
|
(95)
|
(190)
|
(165)
|
|
Income from Continuing Operations |
96
|
129
|
240
|
259
|
172
|
203
|
(1 500)
|
(1 304)
|
430
|
305
|
440
|
421
|
401
|
322
|
320
|
415
|
426
|
491
|
328
|
545
|
328
|
|
Income to Minority Interest |
(6)
|
(7)
|
(9)
|
(9)
|
(5)
|
(7)
|
(7)
|
(9)
|
(9)
|
(7)
|
(9)
|
(9)
|
(10)
|
(7)
|
(10)
|
(14)
|
(8)
|
(28)
|
(62)
|
(126)
|
(70)
|
|
Net Income (Common) |
90
N/A
|
122
+36%
|
230
+89%
|
249
+8%
|
167
-33%
|
196
+17%
|
(1 507)
N/A
|
(1 312)
+13%
|
421
N/A
|
298
-29%
|
431
+45%
|
412
-4%
|
391
-5%
|
315
-19%
|
310
-2%
|
402
+30%
|
418
+4%
|
463
+11%
|
266
-43%
|
419
+58%
|
258
-38%
|
|
EPS (Diluted) |
0.17
N/A
|
0.14
-18%
|
0.28
+100%
|
0.3
+7%
|
0.2
-33%
|
0.24
+20%
|
-1.67
N/A
|
-1.02
+39%
|
0.33
N/A
|
0.23
-30%
|
0.34
+48%
|
0.33
-3%
|
0.31
-6%
|
0.25
-19%
|
0.25
N/A
|
0.32
+28%
|
0.33
+3%
|
0.37
+12%
|
0.21
-43%
|
0.33
+57%
|
0.2
-39%
|